Saturday, October 10, 2026
7:30 PM – 8:00 PM CT – Registration & Dinner
8:00 PM – 9:30 PM CT – CE Symposium
Omni Nashville Hotel
250 Rep. John Lewis Way South
Nashville, Tennessee 37203
Room: Broadway Ballroom F
PROGRAM FEATURES
- Interactive, case-based learning environment
- Downloadable Whiteboard Animation
- Create your own personalized poster
PRESENTING FACULTY
 |
Suresh T. Chari, MD Professor of Medicine Department of Gastroenterology and Hepatology The University of Texas MD Anderson Cancer Center Houston, Texas |
 |
Yasmin Hernandez-Barco, MD Director, Center for Pancreatic Disease at Mass General Brigham Assistant Professor, Harvard Medical School Boston, Massachusetts |
PROGRAM OVERVIEW
This live whiteboard satellite symposium will offer gastroenterologists and advanced practice professionals (nurse practitioners and physicians assistants) a dynamic, visual exploration of immunoglobulin G4-related disease (IgG4-RD). Designed to address important clinical gaps, this symposium aims to break down the complex pathogenesis and clinical manifestations of IgG4-RD. Participants will gain practical strategies to utilize current diagnostic and classification criteria, enhancing their ability to accurately assess disease activity and improve diagnostic precision. Furthermore, the faculty will present recent clinical trial data for emerging targeted therapies, allowing the gastrointestinal care team to integrate evidence-based findings into personalized treatment plans that optimize patient outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists and their associated advanced practice professionals.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe the pathogenesis and clinical manifestations of IgG4-RD
- Utilize diagnostic and classification criteria for IgG4-RD to assess disease activity to improve diagnostic accuracy
- Integrate clinical trial data for targeted therapies to inform treatment strategies for patients with IgG4-RD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.
AAPA CREDIT DESIGNATION STATEMENT – LIVE
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
